Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,380 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Platelet versus plasma CXCL14, coronary artery disease, and clinical outcomes.
Schories C, Martus P, Guan T, Henes JK, Witte A, Müller K, Geisler T, Chatterjee M, Gawaz M, Rath D. Schories C, et al. Among authors: muller k. Res Pract Thromb Haemost. 2023 Apr 25;7(4):100165. doi: 10.1016/j.rpth.2023.100165. eCollection 2023 May. Res Pract Thromb Haemost. 2023. PMID: 37255851 Free PMC article.
Gremlin-1 is an inhibitor of macrophage migration inhibitory factor and attenuates atherosclerotic plaque growth in ApoE-/- Mice.
Müller I, Schönberger T, Schneider M, Borst O, Ziegler M, Seizer P, Leder C, Müller K, Lang M, Appenzeller F, Lunov O, Büchele B, Fahrleitner M, Olbrich M, Langer H, Geisler T, Lang F, Chatterjee M, de Boer JF, Tietge UJ, Bernhagen J, Simmet T, Gawaz M. Müller I, et al. Among authors: muller k. J Biol Chem. 2013 Nov 1;288(44):31635-45. doi: 10.1074/jbc.M113.477745. Epub 2013 Sep 3. J Biol Chem. 2013. PMID: 24003215 Free PMC article.
Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials.
Geisler T, Müller K, Karathanos A, Bocksch W, Gawaz M, Deliargyris E, Bernstein D, Lincoff AM, Mehran R, Dangas G, Stone GW. Geisler T, et al. Among authors: muller k. EuroIntervention. 2014 May;10(1):97-104. doi: 10.4244/EIJV10I1A16. EuroIntervention. 2014. PMID: 24048204 Free article.
Expression of stromal cell-derived factor-1 receptors CXCR4 and CXCR7 on circulating platelets of patients with acute coronary syndrome and association with left ventricular functional recovery.
Rath D, Chatterjee M, Borst O, Müller K, Stellos K, Mack AF, Bongartz A, Bigalke B, Langer H, Schwab M, Gawaz M, Geisler T. Rath D, et al. Among authors: muller k. Eur Heart J. 2014 Feb;35(6):386-94. doi: 10.1093/eurheartj/eht448. Epub 2013 Oct 29. Eur Heart J. 2014. PMID: 24168792
Impact of point-of-care testing for CYP2C19 on platelet inhibition in patients with acute coronary syndrome and early dual antiplatelet therapy in the emergency setting.
Stimpfle F, Karathanos A, Droppa M, Metzger J, Rath D, Müller K, Tavlaki E, Schäffeler E, Winter S, Schwab M, Gawaz M, Geisler T. Stimpfle F, et al. Among authors: muller k. Thromb Res. 2014 Jul;134(1):105-10. doi: 10.1016/j.thromres.2014.05.006. Epub 2014 May 10. Thromb Res. 2014. PMID: 24856643 Clinical Trial.
Platelet expression of transforming growth factor beta 1 is enhanced and associated with cardiovascular prognosis in patients with acute coronary syndrome.
Rath D, Chatterjee M, Müller I, Müller K, Böckmann C, Droppa M, Stimpfle F, Karathanos A, Borst O, Seizer P, Langer H, Schwab M, Gawaz M, Geisler T. Rath D, et al. Among authors: muller k, muller i. Atherosclerosis. 2014 Dec;237(2):754-9. doi: 10.1016/j.atherosclerosis.2014.10.021. Epub 2014 Oct 30. Atherosclerosis. 2014. PMID: 25463116
4,380 results